By Genetic Engineering & Biotechnology News –
A new study led by investigators from the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins Bloomberg School of Public Health, and the Bloomberg~Kimmel Institute for Cancer Immunotherapy may explain why pancreatic cancer is more common and aggressive in older people. The study demonstrates that fibroblasts are altered by aging, which allows them to promote tumor growth.
The findings are published in Cancer Research in an article titled, “Fibroblasts in the aged pancreas drive pancreatic cancer progression.”
